Antioxidant treatment restores prejunctional regulation of purinergic transmission in mesenteric arteries of deoxycorticosterone acetate-salt hypertensive rats.
Norepinephrine (NE) and ATP are co-released by periarterial sympathetic nerves. In mesenteric arteries (MA) from deoxycorticosterone-acetate (DOCA)-salt hypertensive rats, ATP, but not norepinephrine, release is impaired suggesting that their release may be regulated differently. We tested the hypothesis that different calcium channels contribute to ATP and norepinephrine release from sympathetic nerves in vitro in MA from normotensive and DOCA-salt hypertensive rats and that oxidative stress disrupts prejunctional regulation of co-transmission. Excitatory junction potentials (EJPs) were used to measure ATP release. Norepinephrine release was measured amperometrically with carbon-fiber microelectrodes. CdCl2 (30 microM) inhibited norepinephrine release in sham and DOCA-salt arteries by 78% and 85%, respectively. The N-type calcium channel antagonist, omega-conotoxin GVIA (CTX, 0.1 microM) inhibited norepinephrine release by 50% and 67% in normotensive and DOCA-salt arteries, respectively while CTX blocked EJPs. The P/Q-type calcium channel antagonist omega-agatoxin IVA (ATX; 0.03 microM) reduced norepinephrine release in sham but not DOCA-salt arteries and increased EJPs in sham but not DOCA-salt arteries. ATX did not increase EJPs in sham arteries in the presence of the alpha(2)-adrenergic receptor antagonist, yohimbine (1 microM). alpha(2)-Autoreceptor-sensitive EJP facilitation is impaired in DOCA-salt hypertension but this response is restored in DOCA-salt rats treated chronically with the antioxidant, apocynin. Apocynin restored alpha(2)-autoreceptor regulation of norepinephrine release. We conclude that ATP released from periarterial sympathetic nerves is controlled directly by N-type calcium channels. Norepinephrine release is controlled by N and P/Q type calcium channels. Norepinephrine release controlled by P/Q channels acts at alpha(2)-adrenergic receptors to inhibit norepinephrine release suggesting that there may be multiple pools of norepinephrine in periarterial sympathetic nerves. Regulation of norepinephrine release by alpha(2)-autoreceptors and P/Q-type channels is impaired in DOCA-salt hypertension and alpha(2)-autoreceptor function is disrupted by oxidative stress.
Demel
S L
SL
The Neuroscience Program, Michigan State University, East Lansing, MI 48824, USA.
Dong
H
H
Swain
G M
GM
Wang
X
X
Kreulen
D L
DL
Galligan
J J
JJ
D000098:Acetophenones / Q000494:pharmacology*; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D002121:Calcium Channel Blockers / Q000494:pharmacology; D015220:Calcium Channels / Q000502:physiology; D003900:Desoxycorticosterone; D006973:Hypertension / Q000139:chemically induced / Q000378:metabolism* / Q000503:physiopathology; D008297:Male; D008638:Mesenteric Arteries / Q000187:drug effects* / Q000294:innervation / Q000378:metabolism; D009130:Muscle, Smooth / Q000187:drug effects / Q000294:innervation / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D018341:Receptors, Adrenergic, alpha-2 / Q000502:physiology; D011983:Receptors, Purinergic / Q000502:physiology*; D017673:Sodium Chloride, Dietary; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000378:metabolism; D009435:Synaptic Transmission; D020867:omega-Agatoxin IVA / Q000494:pharmacology; D020866:omega-Conotoxin GVIA / Q000494:pharmacology
D000098:Acetophenones; D000975:Antioxidants; D002121:Calcium Channel Blockers; D015220:Calcium Channels; D018341:Receptors, Adrenergic, alpha-2; D011983:Receptors, Purinergic; D017673:Sodium Chloride, Dietary; D020867:omega-Agatoxin IVA; D003900:Desoxycorticosterone; D000255:Adenosine Triphosphate; D020866:omega-Conotoxin GVIA; C056165:acetovanillone; D009638:Norepinephrine
Hypertension. 2008 Aug;52(2):322-9
18606906
Clin Exp Hypertens A. 1985;7(11):1629-45
4085138
Am J Hypertens. 1995 Mar;8(3):287-93
7794579
Jpn Heart J. 1975 Jan;16(1):36-43
1121143
J Cardiovasc Pharmacol. 2007 Jul;50(1):9-16
17666910
Br J Pharmacol. 1996 Sep;119(1):49-56
8872356
Hypertension. 2007 Sep;50(3):547-56
17646575
Br J Pharmacol. 1993 Sep;110(1):281-8
8106104
J Physiol. 2007 Jul 15;582(Pt 2):745-54
17510179
Br J Pharmacol. 2004 May;142(2):267-74
15155535
J Physiol. 2007 Nov 1;584(Pt 3):819-34
17761778
Blood Vessels. 1987;24(3):94-9
3593978
J Hypertens Suppl. 1986 Oct;4(3):S189-92
2431119
Br J Pharmacol. 1998 Dec;125(8):1669-76
9886758
J Neurophysiol. 1993 Aug;70(2):610-20
8410161
Neuropharmacology. 2009 Feb;56(2):368-78
18824011
Auton Neurosci. 2003 Feb 28;104(1):47-57
12559203
Circulation. 2003 Feb 25;107(7):1053-8
12600921
Pflugers Arch. 1995 Oct;430(6):901-8
8594542
Cardiovasc Res. 1998 Aug;39(2):492-505
9798534
Br J Pharmacol. 2005 Feb;144(4):519-27
15678093
Naunyn Schmiedebergs Arch Pharmacol. 1992 Aug;346(2):173-86
1360152
J Neurochem. 2008 Jan;104(2):298-305
17961149
J Pharmacol Exp Ther. 2002 Nov;303(2):439-44
12388622
J Cardiovasc Pharmacol. 1986;8 Suppl 5:S39-43
2427882
Auton Neurosci. 2009 Dec 3;151(2):90-7
19716351
Clin Exp Pharmacol Physiol. 1989 Apr;16(4):333-9
2568204
Hypertension. 1991 Nov;18(5 Suppl):III22-30
1937684
Br J Pharmacol. 1997 Feb;120(3):393-8
9031741
Br J Pharmacol. 2001 Mar;132(6):1201-8
11250870
J Neurosci. 1996 Jul 1;16(13):4155-61
8753877
Hypertension. 2004 May;43(5):1048-54
15051669
Br J Pharmacol. 1999 Jan;126(1):11-8
10051115
Naunyn Schmiedebergs Arch Pharmacol. 1993 Oct;348(4):358-66
7904050
Br J Pharmacol. 1999 Sep;128(1):174-80
10498849
Br J Pharmacol. 1990 May;100(1):180-4
2372658
Exp Physiol. 2009 Jan;94(1):25-30
18805863
Clin Sci (Lond). 2006 Feb;110(2):243-53
16271043
Br J Pharmacol. 2000 Jan;129(1):47-52
10694201
Prog Neurobiol. 1995 Sep;47(1):45-94
8570853
Clin Exp Pharmacol Physiol. 2007 Jul;34(7):601-5
17581215
Jpn Heart J. 1989 Mar;30(2):231-9
2542635
J Pharmacol Exp Ther. 1997 Aug;282(2):691-8
9262332
J Pharmacol Exp Ther. 1999 Jul;290(1):241-6
10381782
Br J Pharmacol. 1999 Dec;128(7):1602-8
10602342